Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies

American Journal of Clinical Pathology

Volumn 105, Issue 3, 1996, Pages 268-276

  Menke, David M ^a   Tiemann, Markus ^b   Camoriano, John K ^c   Chang, Shih Fen ^d   Madan, Ajay ^b   Chow, Matthew ^d   Habermann, Thomas M ^d   Parwaresch, Reza ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF KIEL   (Germany)

^c MAYO CLINIC   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Castleman's disease; Follicular dendritic reticulum cells; Immunohistology; Mantle zone

Indexed keywords

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; B LYMPHOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOPHENOTYPING; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029979594     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.3.268     Document Type: Article

References (38)

1. Case records of the Massachusetts General Hospital (Case 40011). N Engl J Med 1954;250:26-30.
2. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670-683.
3. Frizzera G. Castleman's disease: More questions than answers. Hum Pathol 1985;16:202-205.
4. Ruco LP, Gearing AJ, Pigott R, et al. Expression of ICAM-1, VCAM-1, and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): Evidence for dysplasia of follicular dendritic reticulum cells. Histopalhology 1991;19:523-528.
5. Hanson CA, Frizzera G, Patton DF, et al. Clonal rearrangement for immunoglobulin and T-cell receptor genes in systemic Castleman's disease: Association with Epstein-Barr virus. Am J Pathol 1988;131:84-91.
6. Hall PA, Donaghy M, Cotter FE, et al. An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Histopathology 1989;14:333-346.
7. Isaacson PG. Commentary: Castleman's disease. Histopathology 1989;14:429-432.
8. Bardwick PA, Zvaifler NJ, Gill GN, et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: The POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore) 1980;59:311-322.
9. Takatsuki K, Uchiyama T, Sagawa K, Yodoi J. Plasma cell dyscrasia with polyneuropathy and endocrine disorder: Review of 32 patients. Excerpia Medica International Congress. Series No. 415;1976:454-457.
10. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: A study of 102 cases in Japan. Neurology 1984;34:712-720.
11. Takatsuki K, Sanada I. Plasma cell dyscrasia with polyneuropathy and endocrine disorder: Clinical and laboratory features of 109 reported cases. Jpn J Clin Oncol 1983;13:543-555.
12. Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: A comparison of unicentric. multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol 1992;5:525-530.
13. Feller AC, Wacker HH, Moldenhauer G, et al. Monoclonal antibody Ki-B3 detects a formalin resistant antigen on normal and neoplastic B cells. Blood 1987;70:629-636.
14. Lai R, Visser L, Poppema S. Tissue distribution of restricted leukocyte common antigens: A comprehensive study with protein-and carbohydrate-specific CD45R antibodies. Lab Invest 1991;64:844-854.
15. Hansmann ML, Wacker HH, Gralla J, et al. Ki-B5: A monoclonal antibody unrelated to CD45 recognizes normal and neoplastic human B cells in routine paraffin sections. Blood 1991;77:809-817.
16. Radzun HJ, Hansmann ML, Heidebrecht HJ, et al. Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1p. Lab Invest 1991;65:306-315.
17. Kreipe H, Wacker HH, Heidebrecht HJ, et al. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Am J Pathol 1993;142:1689-1694.
18. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
19. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-229.
20. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-238.
21. Wan JH, Trainor KJ, Brisco MJ, Morley AA. Monoclonality in B-cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 1990;43:888-890.
22. Trainor KJ, Brisco MJ, Wan JH, et al. Gene rearrangement in B-and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood 1991;78:192-196.
23. Menke M, Tiemann M, Parwaresch R. Temperature gradient gel electrophoresis for analysis of a polymerase chain reaction-based diagnostic clonality assay in the early stages of cutaneous T-cell lymphomas. Electrophoresis 1995;16:733-738.
24. Hayakawa K, Hardy RR, Herzenberg LA. Peritoneal Ly-1 B cells: Genetic control, autoantibody production, increased lambda light chain expression. Eur J Immunol 1986;16:450-456.
25. Kasaian MT, Ikematsu H, Casali P. Identification and analysis of a novel human surface CD5-B lymphocyte subset producing natural antibodies. J Immunol 1992;148:2690-2702.
26. Lee KW, Inghirami G, Spatz L, et al. The B cells that express antiMAG antibodies in neuropathy and non-malignant IgM monoclonal gammopathy belong to the CD5 subpopulation. J Neuroimmunol 1991;31:83-88.
27. Solvason N, Kearney JF. The human fetal omentum: A site of B cell generation. J Exp Med 1992;175:397-404.
28. Solvason N, Lehuen A, Kearney JF. An embryonic source of Ly1 but not conventional B cells. Int Immunol 1991;3:543-550.
29. + cells. Proc Soc Exp Biol Med 1990;195:172-182.
30. Powell R, Lightsey A, Thomas W, Marsh W. Castleman's disease in children. J Ped Surg 1986;21:678-682.
31. Stall AM, Adams S, Herzenberg LA, Kantor AB. Characteristics and development of the murine B-1b (Ly-1 B sister) cell population. Ann NY Acad Sci 1992;651:33-43.
32. Taki S, Schmitt M. Tarlinton D, et al. T-cell-dependent antibody production by Ly-1 B cells. Ann NY Acad Sci 1992;651:328-335.
33. Haran-Ghera N, Peled A, Brightman BK, Fan H. Lymphomagenesis in AKR.Fv-1b congenic mice. Cancer Res 1993;53:3433-3438.
34. Rosner A, Peled A, Haran-Ghera N, Canaani E. Analysis of Ly-1 + B-cell populations and IgH rearrangements in "normal" spleens and in lymphomas of AKR/J and AKR Fv-1b mice. Cancer Res 1993;53:2147-2153.
35. van den Oord JJ, De Wolf-Peeters C, Tricot G, Desmet VJ. Distribution of lymphocyte subsets in a case of angiofollicular lymph node hyperplasia. Am J Clin Pathul 1984;82:491-495.
36. Nguyen DT, Diamond LW, Hansmann ML, et al. Castleman's disease: Differences in follicular dendritic network in the hyaline vascular and plasma cell variants. Histopathology 1994;24:437-443.
37. Danon AD, Krishnan J, Frizzera G. Morpho-immunophenotypic diversity of Castleman's disease, hyaline-vascular type: With emphasis on a stroma-rich variant and a new pathogenetic hypothesis. Virchows Arch A Pathol Anal Histopathol 1993;423: 369-382.
38. Radaszkiewicz T, Hansmann ML, Lennert K. Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant. Histopathology 1989;14:11-24.